InVivo Therapeutics Holdings Corporation (NVIV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
One Kendall Square
Cambridge, MA 02139
United States of America (the)
Phone
617 863 5500
Sector
Healthcare
Industry
Biotechnology
Employees
6
First IPO Date
November 15, 2010
| Name | Title | Pay | Year Born |
| Richard Toselli | President, Chief Executive Officer, Chief Medical Officer & Director | 825,204 | 1958 |
| Heather Hamel | Chief Legal Officer & General Counsel | 446,957 | 1990 |
| Richard C. Christopher | Chief Financial Officer & Treasurer | 537,816 | 1970 |
| Joseph Philip Vacanti | Co-Founder | 0 | 1949 |
| Robert S. Langer Jr. | Co-Founder & Member of Scientific Advisory Board | 0 | 1949 |
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.